Abstract

Renal ischemia-reperfusion injury is a major cause of acute kidney injury. In the present study, we investigated the effects of pioglitazone on hypoxia/reoxygenation (H/R) injury in rat renal tubular epithelial cells (RTECs) under normal- (NG) or high-glucose (HG) culture conditions via evaluating oxidative stress and endoplasmic reticulum stress (ERS). The RTECs (NRK-52E cells) were divided into six groups as follows: NG group, HG group, NG + H/R group, HG + H/R group, NG + Pio + H/R group, and HG + Pio + H/R group, among which cells in H/R groups were subjected to 4 h of hypoxia followed by 12 h of reoxygenation. After that, the cells were evaluated using the Cell Counting Kit-8 assay for the determination of their viability and flow cytometry assay for the detection of apoptosis. The levels of superoxide dismutase (SOD), glutathione reductase (GSH), catalase (CAT), and malondialdehyde (MDA) were determined via colorimetric chemical assays. In addition, the expression of ERS-associated proteins, i.e. ATF4, ATF6, GRP78, and CHOP, was determined via western blotting. A HG environment could reduce the viability and increase the apoptotic rate of NRK-52E cells with increased MDA levels and decreased SOD, CAT, and GSH levels, and upregulate the expression of ERS-associated proteins, i.e. ATF4, ATF6, and GRP78. H/R injury could further aggravate changes in the above indicators, but pioglitazone could significantly reverse such changes and alleviate cell injury. Thus, Pioglitazone exhibits a cytoprotective effect on RTECs against H/R injury under NG or HG culture conditions by inhibiting oxidative stress and ERS.

Highlights

  • Diabetes is associated with numerous long-term complications, including kidney disease, cardiovascular diseases, retinopathy, and stroke; all of which reduce the quality of life and the survival rate of patients (Yazdanpanah et al, 2017)

  • The apoptosis of cells in each group was detected via flow cytometry assay, and the results showed that the HG group cells had a statistically significantly higher apoptotic rate than the NG group cells

  • Our previous studies showed that the peroxisome proliferatoractivated receptor gamma (PPAR-g) agonist pioglitazone could protect normal mice against renal ischemia-reperfusion injury (IRI) by inhibiting apoptosis and improving antioxidant effects (Hu et al, 2012; Zou et al, 2013)

Read more

Summary

Introduction

Diabetes is associated with numerous long-term complications, including kidney disease, cardiovascular diseases, retinopathy, and stroke; all of which reduce the quality of life and the survival rate of patients (Yazdanpanah et al, 2017). Pioglitazone Prevents Hypoxia/Reoxygenation Injury numerous studies reporting drugs that exhibit protective effects against renal IRI (Lima-Posada et al, 2019; Tajima et al, 2019; Wei et al, 2019), but there is still no specific drug used in clinical practice for the prevention and treatment of renal IRI. Tawfik reported that pioglitazone alleviates acute IRI-induced renal injuries in diabetic rats via the modulation of oxidative stress and inflammation (Tawfik, 2012). The activation of PPAR-g by pioglitazone exhibits protective effects against gastric mucosal IRI by inducing ERS (Naito et al, 2011). Our study aimed to investigate the effects of pioglitazone on H/R injury in RTECs (NRK-52E cells) under normal- (NG) or high-glucose (HG) culture conditions via evaluating oxidative stress and ERS

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call